+499.5%
MRNA vs BRKR
+100.6%
+398.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BRKR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.5% | -0.7% | -1.6% |
| 7D | +5.5% | +2.5% | +3.0% | +4.2% |
| 30D | +158.7% | +11.5% | +147.2% | +151.0% |
| 3M | +182.1% | -2.4% | +184.5% | +178.6% |
| 6M | +151.8% | +52.3% | +99.5% | +114.1% |
| YTD | +393.6% | +24.5% | +369.1% | +341.5% |
| 1Y | +499.5% | +97.3% | +402.1% | +340.8% |
| All | +499.5% | +100.6% | +398.9% | +340.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BRKR.
Daily Out/Under-Performance
Portfolio return minus BRKR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BRKR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BRKR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling